Morgan Stanley’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.59M Sell
820,421
-148,104
-15% -$287K ﹤0.01% 4854
2025
Q1
$775K Sell
968,525
-320,616
-25% -$257K ﹤0.01% 5122
2024
Q4
$3.04M Buy
1,289,141
+370,829
+40% +$875K ﹤0.01% 4388
2024
Q3
$1.4M Buy
918,312
+89,658
+11% +$136K ﹤0.01% 4851
2024
Q2
$1.09M Buy
828,654
+8,826
+1% +$11.7K ﹤0.01% 4903
2024
Q1
$1.47M Sell
819,828
-558,972
-41% -$1M ﹤0.01% 4753
2023
Q4
$2.3M Buy
1,378,800
+678,184
+97% +$1.13M ﹤0.01% 4845
2023
Q3
$2.17M Sell
700,616
-104,423
-13% -$324K ﹤0.01% 4346
2023
Q2
$2.29M Sell
805,039
-32,816
-4% -$93.5K ﹤0.01% 4337
2023
Q1
$3.3M Sell
837,855
-492,333
-37% -$1.94M ﹤0.01% 4111
2022
Q4
$5.27M Buy
1,330,188
+89,915
+7% +$356K ﹤0.01% 3719
2022
Q3
$11.4M Sell
1,240,273
-77,900
-6% -$716K ﹤0.01% 2806
2022
Q2
$8.11M Buy
1,318,173
+499,533
+61% +$3.07M ﹤0.01% 3288
2022
Q1
$5.26M Sell
818,640
-7,356
-0.9% -$47.2K ﹤0.01% 3633
2021
Q4
$5.41M Sell
825,996
-27,566
-3% -$181K ﹤0.01% 3638
2021
Q3
$4.87M Sell
853,562
-31,637
-4% -$181K ﹤0.01% 3735
2021
Q2
$4.87M Buy
885,199
+34,157
+4% +$188K ﹤0.01% 3804
2021
Q1
$4.93M Sell
851,042
-126,699
-13% -$734K ﹤0.01% 3424
2020
Q4
$6.55M Buy
977,741
+250,502
+34% +$1.68M ﹤0.01% 2969
2020
Q3
$5.32M Buy
727,239
+128,850
+22% +$943K ﹤0.01% 2664
2020
Q2
$2.26M Buy
598,389
+553,151
+1,223% +$2.09M ﹤0.01% 3484
2020
Q1
$83K Sell
45,238
-1,533
-3% -$2.81K ﹤0.01% 5261
2019
Q4
$749K Buy
46,771
+46,071
+6,582% +$738K ﹤0.01% 4706
2019
Q3
$13K Hold
700
﹤0.01% 6131
2019
Q2
$19K Buy
+700
New +$19K ﹤0.01% 5951